These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

548 related items for PubMed ID: 18444820

  • 1. Current treatment options for community-acquired methicillin-resistant Staphylococcus aureus infection.
    Moellering RC.
    Clin Infect Dis; 2008 Apr 01; 46(7):1032-7. PubMed ID: 18444820
    [Abstract] [Full Text] [Related]

  • 2. Skin and soft-tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus.
    Stryjewski ME, Chambers HF.
    Clin Infect Dis; 2008 Jun 01; 46 Suppl 5():S368-77. PubMed ID: 18462092
    [Abstract] [Full Text] [Related]

  • 3. Antibiotic options for treating community-acquired MRSA.
    Powell JP, Wenzel RP.
    Expert Rev Anti Infect Ther; 2008 Jun 01; 6(3):299-307. PubMed ID: 18588495
    [Abstract] [Full Text] [Related]

  • 4. Management of cutaneous lesions associated with an emerging epidemic: community-acquired methicillin-resistant Staphylococcus aureus skin infections.
    Cohen PR, Grossman ME.
    J Am Acad Dermatol; 2004 Jul 01; 51(1):132-5. PubMed ID: 15243539
    [No Abstract] [Full Text] [Related]

  • 5. Community acquired methicillin-resistant Staphylococcus aureus hand infections: case reports and clinical implications.
    Karanas YL, Bogdan MA, Chang J.
    J Hand Surg Am; 2000 Jul 01; 25(4):760-3. PubMed ID: 10913220
    [Abstract] [Full Text] [Related]

  • 6. Epidemiology and treatment of community-associated methicillin-resistant Staphylococcus aureus in children.
    Marcinak JF, Frank AL.
    Expert Rev Anti Infect Ther; 2006 Feb 01; 4(1):91-100. PubMed ID: 16441212
    [Abstract] [Full Text] [Related]

  • 7. Management of methicillin-resistant Staphylococcus aureus (MRSA) skin infections and MRSA colonization.
    Terushkin V, Brownell I.
    J Drugs Dermatol; 2008 Jun 01; 7(6):597-601. PubMed ID: 18561595
    [No Abstract] [Full Text] [Related]

  • 8. The role of primary care prescribers in the diagnosis and management of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections.
    Lawrence KR, Golik MV, Davidson L.
    Am J Ther; 2009 Jun 01; 16(4):333-8. PubMed ID: 19617720
    [Abstract] [Full Text] [Related]

  • 9. Healthy children with invasive community-acquired methicillin-resistant Staphylococcus aureus infections.
    Stankovic C, Mahajan PV.
    Pediatr Emerg Care; 2006 May 01; 22(5):361-3. PubMed ID: 16714967
    [Abstract] [Full Text] [Related]

  • 10. Community-onset methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: impact of antimicrobial therapy on outcome.
    Ruhe JJ, Smith N, Bradsher RW, Menon A.
    Clin Infect Dis; 2007 Mar 15; 44(6):777-84. PubMed ID: 17304447
    [Abstract] [Full Text] [Related]

  • 11. Methicillin-resistant Staphylococcus aureus: an evolving clinical challenge.
    Karchmer AW, Bayer AS.
    Clin Infect Dis; 2008 Jun 01; 46 Suppl 5():S342-3. PubMed ID: 18462088
    [No Abstract] [Full Text] [Related]

  • 12. Community-acquired methicillin-resistant Staphylococcus aureus infections in children.
    Kaplan SL.
    Semin Pediatr Infect Dis; 2006 Jul 01; 17(3):113-9. PubMed ID: 16934705
    [Abstract] [Full Text] [Related]

  • 13. [Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA)--a new challenge in the ambulatory setting?].
    Buehlmann M, Chuard C.
    Rev Med Suisse; 2007 Oct 10; 3(128):2289-90, 2292-3. PubMed ID: 17985605
    [Abstract] [Full Text] [Related]

  • 14. Community-acquired methicillin-resistant Staphylococcus aureus: not just a spider bite.
    Vozdecky C.
    Fam Community Health; 2009 Oct 10; 32(1):76-84. PubMed ID: 19092436
    [Abstract] [Full Text] [Related]

  • 15. Therapy-resistant skin and soft tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus in a young immunocompetent adult.
    Graue N, Korber A, Schmid EN, Rath PM, Dissemond J.
    J Eur Acad Dermatol Venereol; 2008 Jun 10; 22(6):766-7. PubMed ID: 18482040
    [No Abstract] [Full Text] [Related]

  • 16. Daptomycin: rationale and role in the management of skin and soft tissue infections.
    Seaton RA.
    J Antimicrob Chemother; 2008 Nov 10; 62 Suppl 3():iii15-23. PubMed ID: 18829721
    [Abstract] [Full Text] [Related]

  • 17. [Antibiotic susceptibility of Staphylococcus aureus strains responsible for community-acquired skin infections].
    Bernard P, Jarlier V, Santerre-Henriksen A.
    Ann Dermatol Venereol; 2008 Jan 10; 135(1):13-9. PubMed ID: 18342068
    [Abstract] [Full Text] [Related]

  • 18. The role of ancillary antimicrobial therapy for treatment of uncomplicated skin infections in the era of community-associated methicillin-resistant Staphylococcus aureus.
    Gorwitz RJ.
    Clin Infect Dis; 2007 Mar 15; 44(6):785-7. PubMed ID: 17304448
    [No Abstract] [Full Text] [Related]

  • 19. Community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections.
    Whitman TJ.
    Dis Mon; 2008 Dec 15; 54(12):780-6. PubMed ID: 18996280
    [No Abstract] [Full Text] [Related]

  • 20. Community-acquired methicillin-resistant Staphylococcus aureus: time to address the problem.
    Malebranche DJ.
    Expert Rev Anti Infect Ther; 2005 Aug 15; 3(4):459-61. PubMed ID: 16107190
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.